Dunway Test Paper
New Concepts in the Evaluation and Treatment of Dyslipidemia Nathan D. Wong, PhD, FACC Professor and Director Heart Disease Prevention Program Division.
Chapter040
Selective oestogen receptor modulators
Hyperlipidemia and drug therapy for hyperlipidemia
Coronary Heart Disease in Diabetes
Drugs and Dyslipidemias (statins and other lipid and atherosclerosis-modifying drugs) October 18, 2006 Frank F. Vincenzi.
